US20240415852A1
University of Texas System
Compositions and methods are described for oral treatment of gastric cancer. A composition of matter for treatment of gastric cancer includes navitoclax; and Bcl2 siRNA. The composition can include β-glucan and docosahexaenoic acid as a mucoadhesive nanocarrier.